Advertisement
Advertisement
ENTA
Enanta Pharmaceuticals, Inc
11.22
USDSponsored
-0.25
-2.18%
Nov 10, 15:59 UTC -5
Closed
After-Market
11.22
0.00
+0.04%
Enanta Pharmaceuticals, Inc (ENTA)
Enanta Pharmaceuticals, Inc Financial Snapshot
| Market Cap | 326.93M |
| Beta | 0.75 |
| Earnings Per Share (EPS) | -2.41 |
| Price-to-Book (P/B) Ratio | 3.06 |
| Operating Margin | -96.89% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -61.84% |
| Current Ratio | 3.76% |
| Free Cash Flow | -28.99M |
